Identification and application of an aptamer targeting papillary thyroid carcinoma using tissue-SELEX
W Zhong, Y Pu, W Tan, J Liu, J Liao, B Liu… - Analytical …, 2019 - ACS Publications
… thyroid carcinoma and a normal thyroid gland. TC-6 could specifically target intracellular
components of papillary thyroid … could distinguish thyroid carcinoma from other benign thyroid …
components of papillary thyroid … could distinguish thyroid carcinoma from other benign thyroid …
Anaplastic thyroid carcinoma: an overview
WR Cornett, AK Sharma, TA Day, MS Richardson… - Current oncology …, 2007 - Springer
… Thyroid cancer is an uncommon malignancy that accounts for roughly 1… thyroid cancers,
they represent over half of thyroid cancer-related deaths. The relative rarity of anaplastic thyroid …
they represent over half of thyroid cancer-related deaths. The relative rarity of anaplastic thyroid …
Postoperative Surveillance of Differentiated Thyroid Carcinoma: Rationale, Techniques, and Controversies1
NA Johnson, ME Tublin - Radiology, 2008 - pubs.rsna.org
… our understanding of the biology of thyroid carcinoma; aggressive surgery is … thyroid carcinoma
may help differentiate between typical indolent disease and aggressive thyroid carcinoma…
may help differentiate between typical indolent disease and aggressive thyroid carcinoma…
Management of thyroid carcinoma with radioactive 131I
SB Paryani, RJ Chobe, W Scott, J Wells Jr… - International Journal of …, 1996 - Elsevier
… confined to the thyroid, we recommend following patients with annual thyroid scans and serum
… the thyroid, we recommend routine thyroid ablation of 100–150 mCi of radioactive 131 I. …
… the thyroid, we recommend routine thyroid ablation of 100–150 mCi of radioactive 131 I. …
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up
P Carcoforo, M Portinari, L Feggi, S Panareo… - Surgery, 2014 - Elsevier
… Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, accounting for
80% of all such tumors. The optimal strategy for the treatment of patients with PTC combines…
80% of all such tumors. The optimal strategy for the treatment of patients with PTC combines…
Lenvatinib compared with sorafenib as a first-line treatment for radioactive iodine-refractory, progressive, differentiated thyroid carcinoma: real-world outcomes in a …
… The overall survival rate of differentiated thyroid carcinoma (DTC) is reported to be 98% at 5
… as ALK, NTRK, and RET gene fusions and selectively inhibit cancer cell growth with minimal …
… as ALK, NTRK, and RET gene fusions and selectively inhibit cancer cell growth with minimal …
Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinoma
BR Untch, FL Palmer, I Ganly, SG Patel… - Annals of surgical …, 2014 - Springer
… The purpose of this study was to identify the indications for selective completion … Recently,
our institution published the results of patients with resected T1 and T2, N0 thyroid carcinomas …
our institution published the results of patients with resected T1 and T2, N0 thyroid carcinomas …
Treatment of lateral neck papillary thyroid carcinoma recurrence after selective lateral neck dissection
V Strajina, BM Dy, TJ McKenzie, Z Al-Hilli, RA Lee… - Surgery, 2019 - Elsevier
… Lateral neck recurrence after selective neck dissection for papillary thyroid carcinoma may
be difficult to control. Both ethanol ablation and surgery can achieve disease control in the …
be difficult to control. Both ethanol ablation and surgery can achieve disease control in the …
Clinical utility of cabozantinib in the treatment of locally advanced or metastatic differentiated thyroid carcinoma: Patient selection and reported outcomes
L Roof, JL Geiger - Cancer Management and Research, 2023 - Taylor & Francis
… of various highly selective inhibitors targeting specific driver mutations in different forms of
thyroid cancer. Cabozantinib is unique in its profile of targeting medullary thyroid cancer RET …
thyroid cancer. Cabozantinib is unique in its profile of targeting medullary thyroid cancer RET …
Discovery of targeting peptides for selective therapy of medullary thyroid carcinoma
M Böckmann, M Drosten… - The Journal of Gene …, 2005 - Wiley Online Library
… We initially analyzed adenoviral receptor expression in human medullary thyroid carcinoma
(MTC) cells. MTC cell-specific peptides were isolated by biopanning a phage display …
(MTC) cells. MTC cell-specific peptides were isolated by biopanning a phage display …